Pfizer | Patient Daily

Pfizer

Bree Gonzales | Mar 23, 2022

Pfizer and BioNTech request EUA for additional COVID-19 booster shots for people 65 and older

Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'

Bree Gonzales | Aug 28, 2021

Pfizer’s is the first FDA-approved coronavirus vaccine, and now it has a name: Comirnaty

Harmony Valdoz | Aug 28, 2018

Pharmaceutical industry group backs proposal to share drug savings with Medicare beneficiaries

Press release submission | Apr 28, 2018

PFIZER: MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy

Press release submission | Apr 28, 2018

PFIZER: Pfizer Provides Update on Proposed Trastuzumab Biosimilar

Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval

Carol Ostrow | Dec 26, 2017

Bristol-Myers Squibb, Pfizer, others aim to raise awareness of stroke risk in atrial fibrillation patients

Trending

Patient Daily News Service | Jan 22, 2025

National Pharmacists Group to DOGE: Start search for 'waste and inefficiencies in federal programs' with the pharmacy benefit managers

+ Pharmaceuticals

Patient Daily | Jan 17, 2025

Understanding symptoms and treatment options for long-term effects of COVID-19

Patient Daily News Service | Jan 16, 2025

FTC Chair: Report Finds 'Three Major Pharmacy Benefit Managers Hiked Costs for a Wide Range of Lifesaving Drugs, Including Medications to Treat Heart Disease and Cancer'